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Abstract. 
 
Matrix vesicles have a critical role in the ini-
tiation of mineral deposition in skeletal tissues, but the 
ways in which they exert this key function remain 
poorly understood. This issue is made even more in-
triguing by the fact that matrix vesicles are also present 
in nonmineralizing tissues. Thus, we tested the novel 
hypothesis that matrix vesicles produced and released 
by mineralizing cells are structurally and functionally 
different from those released by nonmineralizing cells. 
To test this hypothesis, we made use of cultures of chick 
embryonic hypertrophic chondrocytes in which miner-
alization was triggered by treatment with vitamin C and 
phosphate. Ultrastructural analysis revealed that both 
control nonmineralizing and vitamin C/phosphate-
treated mineralizing chondrocytes produced and re-
leased matrix vesicles that exhibited similar round 
shape, smooth contour, and average size. However, un-
like control vesicles, those produced by mineralizing 
chondrocytes had very strong alkaline phosphatase ac-
tivity and contained annexin V, a membrane-associated 
 
protein known to mediate Ca
 
2
 
1
 
 influx into matrix vesi-
cles. Strikingly, these vesicles also formed numerous 
apatite-like crystals upon incubation with synthetic car-
tilage lymph, while control vesicles failed to do so. 
Northern blot and immunohistochemical analyses 
showed that the production and release of annexin 
V-rich matrix vesicles by mineralizing chondrocytes 
were accompanied by a marked increase in annexin V 
expression and, interestingly, were followed by in-
creased expression of type I collagen. Studies on em-
bryonic cartilages demonstrated a similar sequence of 
phenotypic changes during the mineralization process 
in vivo. Thus, chondrocytes located in the hypertrophic 
zone of chick embryo tibial growth plate were charac-
terized by strong annexin V expression, and those lo-
cated at the chondro–osseous mineralizing border ex-
hibited expression of both annexin V and type I 
collagen. These findings reveal that hypertrophic chon-
drocytes can qualitatively modulate their production of 
matrix vesicles and only when induced to initiate min-
eralization, will release mineralization-competent ma-
trix vesicles rich in annexin V and alkaline phosphatase. 
The occurrence of type I collagen in concert with carti-
lage matrix calcification suggests that the protein may 
facilitate crystal growth after rupture of the matrix vesi-
cle membrane; it may also offer a smooth transition 
from mineralized type II/type X collagen-rich cartilage 
matrix to type I collagen-rich bone matrix.
 
B
 
iomineralization 
 
has a key role in the normal re-
placement of the cartilaginous skeleton with defin-
itive bone skeleton via endochondral ossification
during prenatal and early postnatal life. In this complex
process, mineralization is tightly controlled both tempo-
rally and spatially and is limited to a few layers of hyper-
trophic chondrocytes at the chondro–osseous border. Min-
eralization is also crucial for the development and function
of other mineralized tissues, such as the intramembranous
craniofacial bones and teeth. Changes in mineralization
can have serious pathological ramifications. Excessive min-
eral deposition accompanies atherosclerosis and osteoar-
thritis, probably causing loss of normal tissue elasticity and
resilience (2, 3, 65). Despite the fundamental and multiple
roles of mineralization, the mechanisms regulating it re-
main poorly understood.
Much effort has been devoted to identifying and charac-
terizing the structure and/or components that initiate min-
eralization, which is the nucleational site for calcification.
Studies have suggested that focal accumulations of pro-
teoglycans in hypertrophic cartilage may represent such
nucleational sites (25, 26, 53). Because of their high nega-
tive charge density, the proteoglycans would bind large
amounts of Ca
 
2
 
1
 
 ions; inorganic phosphate would then
displace the concentrated Ca
 
2
 
1
 
, leading to salt precipita-
tion and mineral deposition (25, 26, 53). Other studies
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have provided evidence that matrix vesicles may represent
the nucleational site for mineralization (5, 6, 14). These ves-
icles are cell-derived, membrane-bound microstructures,
averaging 30 to 100 nm in diameter, that are present in
mineralizing tissues including hypertrophic cartilage, bone,
and tendons.
Matrix vesicles contain several specific proteins, includ-
ing alkaline phosphatase and annexins II, V, and VI (6,
21). Annexin V appears to play major roles in the function
of the vesicles, particularly during the onset of calcification
when the first mineral phase forms and grows inside the
vesicle lumen. The protein mediates the influx of Ca
 
2
 
1
 
ions into the vesicles, which in turn permit mineral growth
from a preexisting nucleational core complex (30, 34, 59).
This core complex is Ca
 
2
 
1
 
 and P
 
i
 
 rich and is thought to
form intracellularly before the vesicles are released (30,
69, 71). In addition, annexin V binds directly to types II
and X collagen, thereby anchoring the vesicles to the ex-
tracellular matrix (32, 34, 68). The second step of vesicle-
mediated mineralization is characterized by crystal growth
from the vesicle lumen into the extracellular matrix. Once
the crystals rupture the vesicle membrane and penetrate
the extracellular matrix, additional proteins probably reg-
ulate apatite deposition and growth. For example, in tur-
key tendons the apatitic crystals emerging from matrix ves-
icles exhibit directed growth along type I collagen fibrils,
suggesting a role of this collagen in crystal elongation, ori-
entation, and propagation (9, 10, 13, 36).
If indeed matrix vesicles have the key role of initiating
mineralization it would be reasonable to expect that the
vesicles be present exclusively at the mineralization front
of calcifying tissues and be absent in areas of the same tis-
sues devoid of mineral and in tissues that do not mineral-
ize. Unfortunately, this is not the case, since matrix vesi-
cles are present in noncalcifying tissues such as normal
articular cartilage (8, 15, 16, 67). One explanation for this
puzzle is that nonmineralizing tissues may contain compo-
nents that inhibit the function of matrix vesicles and block
mineralization. Another equally interesting possibility is
that matrix vesicles are not all equal and that tissues en-
gaged in mineralization produce mineralization-competent
vesicles, whereas nonmineralizing tissues produce vesicles
unable to initiate mineralization. Support for this possibil-
ity can be found in studies demonstrating an increase of
alkaline phosphatase activity in matrix vesicles as they ap-
proach the calcification front in growth plate cartilage and
in articular cartilage matrix vesicles that lie close to the un-
derlying bone (41, 55). We have tested the latter possibility
by using mineralization systems that we have developed in
recent years; they consist of maturing and hypertrophic
chondrocytes isolated from chick embryos and maintained
in monolayer culture in which mineralization can be trig-
gered rapidly and efficiently by treatment with vitamin C
or retinoid acid (28, 29, 37). Specifically, we have asked
whether mineralizing hypertrophic chondrocytes produce
vesicles that are mineralization competent and contain
annexin V whereas nonmineralizing cells do not. We have
also asked whether production of such mineralization-
competent vesicles is followed by the initiation of type I
collagen expression by the mineralizing chondrocytes, thus
suggesting a role for this matrix component in the propa-
gation of vesicle-mediated mineralization of cartilage matrix.
 
Materials and Methods
 
Cell Culture
 
Chondrocytes were isolated from the hypertrophic region of day 19 em-
bryonic chick tibia growth plate cartilage by trypsin followed by collage-
nase digestion as described previously (49). Cells were plated at an initial
density of 3 
 
3
 
 10
 
6
 
 cells into 100-mm tissue culture dishes in Dulbecco’s
modified high glucose Eagle’s medium (HG-DMEM; GIBCO BRL, Gaith-
ersburg, MD) containing 10% defined fetal bovine serum (Hyclone, Lo-
gan, UT), 2 mM 
 
l
 
-glutamine, and 50 U/ml penicillin and streptomycin
(complete medium). Chondrocytes reached confluency in 
 
z
 
7 d. Once
confluent, cells were treated with 50 
 
m
 
g/ml of freshly prepared vitamin C
and 2.5 mM phosphate. Medium was changed daily.
 
RNA Isolation and Analysis
 
Total RNAs were isolated from different zones of tibia growth plate carti-
lage from day 19-old chick embryos and from cultured cells by the method
of Chomczynski and Sacchi (17). For Northern blot analysis, 10 
 
m
 
g of total
RNA was denatured by glyoxalation, fractionated on 1% agarose gels,
and transferred to Hybond-N membranes by capillary blotting as de-
scribed previously (46, 50). Blots were stained with 0.04% methylene blue
to verify that each sample has been transferred efficiently. Blots were hy-
bridized in 6
 
3
 
 SSC, 5
 
3
 
 Denhardt’s solution, 100 
 
m
 
g/ml sheared salmon
sperm DNA, 2% SDS, and 50% formamide at 45
 
8
 
C overnight with 
 
32
 
P-labeled
cDNA probes. The cDNA clones used to prepare probes for type X col-
lagen, annexin V, and type I collagen mRNAs are pDLr10 (40), pACII.1
(52), and pCOL3 (72), respectively. Blots were washed at high stringency
(0.1
 
3
 
 SSC, 0.1% SDS at 60
 
8
 
C) and exposed to Kodak X-ray films at
 
2
 
70
 
8
 
C.
 
Immunofluorescence Staining and Alizarin
Red S Staining
 
This procedure was carried out as previously described (33, 35). Briefly,
longitudinal 8-
 
m
 
m-thick frozen sections from day 19 chick embryonic tibia
growth plate cartilage were fixed for 10 min in ice-cold acetone. Before
immunostaining, the fixed sections were decalcified with 0.1 M EDTA,
pH 7.4, for 1 h and pretreated with sheep testicular hyaluronidase (2 mg/ml;
Sigma Chemical Co., St. Louis, MO) for 30 min at 37
 
8
 
C. Cells were
washed with PBS, pH 7.4, and fixed with 70% ethanol. The sections or
fixed cells were incubated with a mixture of monoclonal mouse anti-chick
type I collagen IgG and polyclonal rabbit anti–chick type X collagen IgG
or a mixture of monoclonal mouse anti–chick type I collagen IgG and
polyclonal rabbit anti–chick annexin V IgG for 3 h at room temperature,
followed by incubation with a mixture of rhodamine-conjugated goat anti–
mouse IgG and FITC-conjugated goat anti–rabbit IgG (Cappel, Durham,
NC) for 1 h at room temperature.
To localize calcium deposits, sections were stained with 0.5% alizarin
red S solution, pH 4.0, for 5 min at room temperature. To verify that al-
izarin staining was specific, sections were decalcified and then stained with
alizarin red S. Stained sections were washed three times with water and
ethanol. Sections and cells were examined under a Zeiss microscope and
viewed in both epifluorescence and phase modes.
 
Isolation of Matrix Vesicles and Ca
 
2
 
1
 
 Uptake Studies
 
Matrix vesicles were isolated from cultured chondrocytes by enzymatic di-
gestion as described previously (20, 34). Briefly, adherent chondrocytes
were washed with PBS and then incubated in PBS containing 0.1% trypsin
(type III; Sigma Chemical Co.) at 37
 
8
 
C for 30 min. The trypsin was re-
moved by washing with PBS, and the cells were then treated with crude
collagenase (500 U/ml; type IA; Sigma Chemical Co.) at 37
 
8
 
C for 3 h. Ma-
trix vesicles were harvested by differential ultracentrifugation as de-
scribed previously (20). Three dishes (100 mm) of confluent chondrocyte
cultures were used to isolate matrix vesicle fractions containing between
300 and 500 
 
m
 
g of total proteins. For Ca
 
2
 
1
 
 uptake studies, matrix vesicles
(50 
 
m
 
g of total proteins) were sedimented by centrifugation and resus-
pended in 500 
 
m
 
l of synthetic cartilage lymph; synthetic cartilage lymph,
pH 7.4, contained 2 mM Ca
 
2
 
1
 
 and 1.42 mM P
 
i
 
, in addition to 104.5 mM
Na
 
1
 
, 133.5 mM Cl
 
2
 
, 63.5 mM sucrose, 16.5 mM Tris, 12.70 mM K
 
1
 
, 5.55
mM 
 
d
 
-glucose, 1.83 mM HCO
 
3
 
2
 
, 0.57 mM Mg
 
2
 
1
 
, and 0.57 mM SO
 
4
2
 
2
 
. The
matrix vesicle suspension was incubated at 37
 
8
 
C, centrifuged, and resus- 
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pended in 50 
 
m
 
l of 0.1 M HCl. Aliquots of the suspensions were analyzed
for calcium using the microcolorimetric method of Baginski et al. (11).
 
Fourier Transform Infrared Spectroscopy
 
Matrix vesicle samples were freeze dried and stored desiccated. Each sam-
ple was analyzed by Fourier transform infrared spectroscopy (FT-IR; Magna
IR 550 spectrometer; Nicolet Instrument Technologies, Madison, WI), op-
erated in the diffuse reflectance mode. Vesicle preparations were milled in
an agate mortar and layered on KBr (ratio of KBr to sample, 300:1, wt/
wt); routinely, 300 interferograms were collected at 4 cm
 
2
 
1
 
 resolution;
background due to organic matrix was subtracted using a chondrocyte
membrane preparation. Spectra were coadded and the resultant inter-
ferograms Fourier transformed, and second derivative spectra (1,200–500
cm
 
2
 
1
 
) were obtained using a software package (Omnic; Nicolet Instru-
ment Technologies).
 
Electron Microscopy
 
Matrix vesicles were sedimented by centrifugation, and the resulting pel-
lets were fixed in Karnovsky’s fixative, postfixed in 2% osmium tetroxide,
dehydrated in a graded series of ethanol, and embedded in epoxy resin.
Ultrathin sections were cut on an Ultratome (LKB Instruments, Inc., Stock-
holm, Sweden), picked up on formvar-coated grids, and contrasted with
uranyl acetate and lead citrate. Specimens were evaluated in a transmis-
sion electron microscope (100CX II; JEOL USA, Peabody, MA) operated
at 80 kV.
To analyze matrix vesicle preparations for calcium and sulfur, freeze-
dried matrix vesicle pellets were mounted on SEM specimen stubs and
coated with carbon. The samples were analyzed using a scanning electron
microscope (T330A; JEOL USA) and EDS microanalysis system (Delta I;
Kevex Corp., Foster City, CA).
 
Dot Blot Analysis
 
To analyze for cartilage proteoglycan (aggrecan) in matrix vesicle prepa-
rations, aliquots of matrix vesicle fractions (2 
 
m
 
g of total protein) were
dotted onto nitrocellulose filters. After blocking with low fat milk powder
the filters were immunostained with polyclonal antibodies against chicken
aggrecan followed by secondary horseradish-conjugated anti–rabbit IgG
(Rockland Inc., Gilbertsville, PA) and 
 
a
 
-chloronaphthol as color sub-
strate. The optical density of the color reaction was determined using a
densitometer. To determine the amount of aggrecan in the matrix vesicle
fractions, purified aggrecan in different concentrations (1–20 
 
m
 
g) was ap-
plied onto nitrocellulose filters and immunostained with the aggrecan an-
tibodies.
 
Antibodies
 
The preparation and specificity of a polyclonal antibody against chicken
annexin V were described elsewhere (42). The preparations of antibodies
against chick aggrecan and types X, II, and I collagen were described else-
where (1, 23, 38, 47). These antibodies have been shown to be specific and
do not cross-react with other collagens or matrix proteins (1, 23, 38, 47).
 
SDS–polyacrylamide Gel Electrophoresis
and Immunoblotting
 
Samples were dissolved in 3% SDS sample buffer with dithiothreitol, de-
natured at 100
 
8
 
C for 3 min, and analyzed by electrophoresis in 8 or 10%
(wt/vol) polyacrylamide gels. Gels were stained with Coomassie blue, or
proteins were electroblotted onto nitrocellulose filters (Schleicher & Schuell,
Inc., Keene, NH). After blocking with low fat milk protein, blotted pro-
teins were immunostained with the appropriate antibodies using peroxi-
dase-conjugated secondary antibodies and 
 
a
 
-chloronaphthol as a color
substrate.
 
Other Methods
 
To measure the protein content and alkaline phosphatase activity in the
cell layer, cells were washed in PBS and then suspended in 10 mM Tris/
HCl, pH 7.5, 0.1% Triton X-100, 0.5 mM MgCl
 
2
 
. Protein content was ana-
lyzed by the BCA assay from Pierce (Rockford, IL). Alkaline phos-
phatase activity was determined using 
 
p
 
-nitrophenyl phosphate as sub-
strate (63). To measure calcium and phosphate levels, the suspension was
centrifuged, and the pellet was resuspended in 0.1 M HCl. Inorganic phos-
phate was determined by a modified method of Ames (4).
 
Results
 
Calcification and Production of Matrix Vesicles in 
Chondrocyte Cultures
 
In a first series of experiments we investigated whether
mineralization in chondrocyte cultures and the formation
of matrix vesicles were affected by vitamin C and phos-
phate treatment. Chondrocytes isolated from the hyper-
trophic zone of day 19 embryonic chick tibia growth plate
cartilage were cultured in control medium or medium con-
taining 50 
 
m
 
g/ml vitamin C and 2.5 mM phosphate. After
14 d, mineralization in vitamin C/phosphate-treated chon-
drocyte cultures was observed (Fig. 1 
 
B
 
); bright field mi-
croscopy failed to show mineral in the matrix of untreated
chondrocytes (Fig. 1 
 
A
 
). Vitamin C increased the activity
of alkaline phosphatase; in contrast, phosphate did not
stimulate alkaline phosphatase activity (Fig. 2 
 
A
 
). Cultures
supplemented with vitamin C or phosphate led to a 4-fold
elevation in the calcium and phosphate content of the cell
layer; together both reagents led to a more than 12-fold in-
crease in ion accumulation (Fig. 2, 
 
B
 
 and 
 
C
 
). After 7 d, lit-
tle calcification was evident in vitamin C and phosphate-
supplemented cultures (data not shown).
Since the vitamin C and phosphate treatment signifi-
cantly increased the rate and extent of calcification of
chondrocyte cultures, we determined next whether this
treatment affected the composition of matrix vesicles. Ma-
trix vesicles were isolated from the cell layers of day 14
control nonmineralizing and vitamin C/phosphate-treated
mineralizing cultures by mild trypsin and collagenase di-
gestion followed by ultracentrifugation. Table I summa-
rizes the general composition of the vesicles. The total
protein content of vesicles from control cultures was about
half that of vesicles from mineralizing cultures. Most im-
portant was the finding that the alkaline phosphatase ac-
tivity and the Ca
 
2
 
1
 
 and P
 
i
 
 content of the vesicles from min-
eralizing cultures were over 300- and 10-fold higher than
those in vesicles from nonmineralizing control cells, re-
spectively (Table I).
Given the quite different characteristics of vesicles from
Figure 1. Phase contrast micrographs of cultures of hypertrophic
chondrocytes treated with vitamin C and phosphate. Tibia chon-
drocytes were grown to confluency and then maintained in cul-
ture for a further 14 d in the absence (A) or presence of vitamin C
(50 mg/ml) and 2.5 mM phosphate (B). Note the presence of abun-
dant opaque mineral deposits in vitamin C/phosphate-treated cul-
tures (B). 
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control and mineralizing cultures, we asked whether the
vesicles would also differ in their ability to take up Ca
 
2
 
1
 
.
Vesicles isolated from control cultures showed no signifi-
cant Ca
 
2
 
1
 
 uptake after 24 h incubation in synthetic carti-
lage lymph (2% of the total amount of Ca
 
2
 
1
 
 present in the
reaction mixture), while vesicles isolated from mineraliz-
ing cultures accumulated 
 
z
 
30% of the total amount of
Ca
 
2
 
1
 
 in the reaction mixture (Table I). Similar rates of
 
z
 
30% Ca
 
2
 
1
 
 uptake over 24 h test period were also found
in matrix vesicles isolated from calcified cartilage (30, 34).
Ca
 
2
 
1
 
 uptake by matrix vesicles is probably mediated by
annexin V (30, 34, 59); in addition, annexin V mediates
binding of types II and X collagen to matrix vesicles (32,
34, 68). Binding of these collagens to matrix vesicles stimu-
lates Ca
 
2
 
1
 
 uptake by these particles (30, 34). Thus, we
asked whether the differences in Ca
 
2
 
1
 
 uptake seen above
reflected differences in annexin V and types II and X col-
lagen content in the vesicles. Vesicle samples were sub-
jected to SDS-PAGE and immunoblotting analyses. Fig. 3
(lanes 
 
b
 
 and 
 
d
 
, control matrix vesicles; lanes 
 
a
 
 and 
 
c
 
, min-
eralizing matrix vesicles) shows that there were several
major differences in the protein profile of vesicles from con-
trol (Fig. 3, lane 
 
b
 
) versus mineralizing cultures (Fig. 3,
lane 
 
a
 
). For example, a major band with an apparent mo-
lecular mass of 120 kD was present in control vesicles (Fig. 3,
lane 
 
b
 
) but absent in mineralizing vesicles (lane 
 
a
 
). Immuno-
blot analysis using antibodies against annexin V revealed
that indeed only matrix vesicles from mineralizing chon-
drocytes contained annexin V (Fig. 3, lane 
 
c
 
), while vesi-
cles from control cultures showed no appreciable amounts
of this protein (Fig. 3, lane 
 
d
 
). Immunoblot analyses using
antibodies against types I, II, and X collagen revealed that
only mineralizing matrix vesicles contained types II (Fig. 4,
lane 
 
a
 
) and X collagen (Fig. 4, lane 
 
c
 
), while no immunostain-
ing was obtained in control matrix vesicles (Fig. 4, lane 
 
b
 
and 
 
d
 
). No appreciable amounts of type I collagen were
detected in both mineralizing (Fig. 4, lane 
 
e
 
) and control
matrix vesicles (Fig. 4, lane 
 
f
 
).
Ultrastructural analysis revealed that matrix vesicles
freshly isolated from vitamin C/phosphate-treated cultures
varied in size, shape, and content. In general, they were
round to oval with diameters ranging from 30 to 100 nm. A
few preformed crystallites were observed in these freshly
isolated matrix vesicles (Fig. 5 
 
A
 
). After 24 h incubation in
synthetic cartilage lymph at 37
 
8
 
C, numerous needle-like
crystals were formed in association with matrix vesicles
(Fig. 5 
 
B
 
); by 48 h, these vesicle preparations were heavily
Figure 2. Histograms show-
ing alkaline phosphatase ac-
tivity and calcium and phos-
phate content of chondrocyte
cultures supplemented with
or without vitamin C and/or
phosphate. Confluent cul-
tures of day 19 chick embry-
onic growth plate chondro-
cytes were treated for 14 d
with vitamin C (50 mg/ml)
and 2.5 mM phosphate. Con-
trol cultures were maintained
for 14 d in the absence of either of these supplements. Cultures were harvested and alkaline phosphatase, Ca21, and Pi content deter-
mined. Data were obtained from three different cultures; values are mean 6 SE.
 
Table I. Characterization of Matrix Vesicles Isolated from 
Control Chondrocyte Cultures or from Cultures Treated with 
Vitamin C and Phosphate
 
MV-fraction
from control cells
MV-fraction
from Vit.C/P
 
i
 
-treated cells
 
Protein content 56 
 
6
 
 79 2
 
‡  6  5
(mg/mg cell protein)
Alkaline phosphatase activity 125 6 32 45,112‡ 6 3,795
(nmol/min/mg protein)*
Calcium content 0.037 6 0.013 0.462‡ 6 0.086
(mmol/mg protein)
Phosphate content 0.034 6 0.009 0.381‡ 6 0.126
(mmol/mg protein)
Calcium uptake after 24 h 2.3 6 0.9 29.3‡ 6 4.1
(percent of total Ca21 in 1 ml
of reaction mixture)
*Alkaline phosphatase activity is expressed as nmol of p-nitrophenyl phosphate hy-
drolyzed per min/mg of protein.
‡Significantly different from levels in control matrix vesicles (P , 0.001).
Four different samples of matrix vesicles isolated from control or vitamin C/phos-
phate-treated cultures were analyzed; values shown are means 6 S.E. (n 5 4). The
protein content of the vesicles was normalized to 1 mg of cell protein.
Figure 3. SDS-PAGE and
immunoblot analysis of ma-
trix vesicles isolated from vi-
tamin C/phosphate-treated
and control chondrocyte cul-
tures. Pellets of matrix vesi-
cles which were isolated from
the cell layer of vitamin C/
phosphate-treated (lanes a
and  c) or control chondro-
cyte cultures (lanes b and d)
were boiled in SDS–sample
buffer, analyzed by SDS-PAGE on 10% (wt/vol) polyacrylamide
gels, and stained with Coomassie blue to visualize the protein
bands (lanes a and b), or the proteins were transferred electro-
phoretically to nitrocellulose filters for immunoblot analysis of
annexin V (lanes c and d). Note the difference in the protein
profile of both matrix vesicle preparations. Also note the im-
munostaining for annexin V (AV) in vesicles isolated from vita-
min C/phosphate-treated cultures (lane c), whereas there was no
staining in vesicles prepared from control cultures (lane d).Kirsch et al. Mineralization-competent Matrix Vesicles 1153
calcified (Fig. 5 C). Strikingly, no needle-like crystals were
formed in association with matrix vesicles isolated from
control cultures (Fig. 5 D).
To determine the nature of the crystals, vesicle samples
incubated in synthetic lymph for 24 h were analyzed by
Fourier transform infrared spectroscopy. Fig. 6 A shows
the second derivative spectra of the n1n3 phosphate region
(1,200–950 cm21) of matrix vesicle preparations obtained
from mineralizing cultures. Peaks can be seen at 960, 1,025,
1,102, 1,065, and 1,157 cm21, consistent with apatite struc-
ture. In contrast, the spectra of the n1n3 region of control
vesicles exhibited no such peaks but rather a nondescript
pattern consistent with lack of a mineral phase (Fig. 6 C).
Fig. 6, B and D shows the second derivative structure in
the n4 domains (640–500 cm21). Peaks at 626 and 539 cm21,
also characteristic of HPO4 apatites, were clearly evident
in mineralizing vesicle samples (Fig. 6 B) but were mark-
edly reduced in control samples (Fig. 6 D). Both samples
contained prominent bands at 561, 576, and 602 cm21
which are representative of phosphate ions (Fig. 6, B and D).
Previous studies have suggested that proteoglycans are
involved in the nucleation of cartilage mineralization (25,
26, 53). Thus, it is possible that the different calcification
properties of matrix vesicles isolated from control and
mineralizing chondrocyte cultures may be due to differ-
ences in vesicle-associated proteoglycan content. To ana-
lyze this possibility we carried out two quantitative analy-
ses of proteoglycan content. In the first set of experiments,
aliquots of the matrix vesicle preparations (2 mg of total
protein) were dotted onto nitrocellulose filters and immu-
nostained with antibodies against the cartilage proteogly-
can aggrecan (Fig. 7 B); as a control, purified aggrecan at
concentrations from 1 to 20 mg/dot was also applied to the
filters (Fig. 7 A). Vesicle preparations from both control
and vitamin C/phosphate-treated cultures exhibited im-
munostaining for aggrecan (Fig. 7 B). However, densito-
metric analysis revealed that similar amounts of aggrecan
were present in both preparations (192 mg/mg total pro-
tein in vesicles from control cultures; 141 mg/mg total pro-
tein in vesicles from mineralizing cultures). In a second set
of experiments we analyzed the sulfur and calcium content
in the vesicle preparations using scanning electron micros-
copy and EDS microanalysis. A similar sulfur content was
observed in vesicles from control cultures (Fig. 7 C, peak
labeled with S) and mineralizing cultures (Fig. 7 D, peak
labeled with S). Interestingly, strong calcium peaks were
only detected in vesicles from mineralizing cultures (Fig.
7 D, peaks labeled with Ca) but were absent in vesicles
from control cultures (Fig. 7 C). In addition, mineralizing
matrix vesicles contained more phosphate than control
vesicles (Fig. 7, C and D, peaks labeled with P). These
findings indicate that differences in proteoglycan content
cannot account for the differences in mineralizing proper-
ties of vesicles produced by control and mineralizing chon-
drocytes.
Annexin V and Type I Collagen Expression
We asked next whether the presence of annexin V-rich,
mineralization-competent matrix vesicles in mineralizing
cultures reflected increased gene expression of this pro-
tein. We also asked whether possible changes in annexin V
expression may be accompanied by changes in type I col-
lagen expression, given the possible prominent role of this
matrix protein in mineral propagation (9, 10, 13, 36).
Chondrocytes were cultured for 7 and 14 d in the ab-
sence or presence of vitamin C and phosphate, and total
cellular RNAs were then isolated and examined by North-
ern blot analysis. Indeed, annexin V gene expression in-
creased several fold in the vitamin C/phosphate-treated
cultures already by day 7 (Fig. 8, Day 7, AV) and remained
high by day 14 (Fig. 8, Day 14, AV). Likewise, gene ex-
pression of type X collagen, a marker of hypertrophic
chondrocytes, was also markedly stimulated (Fig. 8, a1(X)).
Interestingly at day 14, vitamin C/phosphate-treated cul-
tures exhibited high levels of type I collagen expression
compared to control cultures (Fig. 8, Day 14, a1(I)), while
only low levels of type I collagen expression were detected
after 7 d of treatment (Fig. 8, Day 7, a1(I)). Thus, during
induction of mineralization in chondrocyte cultures, ex-
pression of annexin V and type X collagen genes increases
first and is followed by increased expression of type I col-
lagen.
To ascertain whether the above changes in gene expres-
sion were accompanied by corresponding changes at the
protein level, cultures were immunostained with antibod-
ies against annexin V, type X collagen, or type I collagen.
Control cultures were immunopositive for type X collagen
but exhibited no staining for type I collagen on day 7 (not
shown) and day 14 (Fig. 9, B and C), even though low lev-
els of a1(I) mRNA were detectable on day 14 (Fig. 8, Day
14, a1(I)); the control cells were also immunopositive for
Figure 4. Immunoblot analyses of matrix vesicles from vitamin
C/phosphate-treated and control chondrocyte cultures using anti-
bodies against types I, II, and X collagen. Pellets of matrix vesi-
cles isolated from vitamin C/phosphate-treated (lanes a, c, and e)
or control chondrocyte cultures (lanes b, d, and f) were analyzed
by SDS-PAGE on 8% (wt/vol) polyacrylamide gels and trans-
ferred electrophoretically to nitrocellulose filters for immunoblot
analysis of type II collagen (II, lanes a and b), type X collagen (X,
lanes c and d) and type I collagen (I, lanes e and f). Note the im-
munostaining for type II collagen (lane a) and type X collagen
(lane c) in vesicles isolated from vitamin C/phosphate-treated
cultures, whereas there was no staining in vesicles prepared from
control cultures (lanes b and d). No immunostaining for type I
collagen was obtained in both vesicle preparations (lanes e and f).
(Lane g [I Std.]) Purified type I collagen immunostained with an-
tibodies against type I collagen.The Journal of Cell Biology, Volume 137, 1997 1154
annexin V (Fig. 9 A). Cultures treated with vitamin C and
phosphate were strongly immunopositive for annexin V
and type X collagen on day 7, while only a few cells were
positive for type I collagen (Fig. 9, D–F). After 14 d of
treatment, the cultures not only exhibited strong annexin
V and type X collagen immunoreactivity (Fig. 9, G and H)
but also strong type I collagen immunoreactivity, resulting
in .90% of the cells being surrounded by a type I col-
lagen-rich matrix (Fig. 9 I).
Annexin V and Type I Collagen Expression in Tibia 
Growth Plate Cartilage
Our in vitro studies above show that chondrocytes under-
going mineralization first upregulate annexin V gene ex-
pression followed by onset of type I collagen expression
and matrix calcification. We determined next whether a
similar sequence of events occurs in vivo. To address this
question we examined annexin V and type I collagen gene
expression in the developing chick tibia growth plate carti-
lage in vivo by Northern blots and immunohistochemistry.
The proliferative, upper and lower hypertrophic zones
of tibia growth plate cartilage were microsurgically iso-
lated from day 19 chick embryos; the resulting tissue frag-
ments were processed for RNA isolation and Northern
blot analyses. We found that the upper hypertrophic zone
contained large amounts of annexin V transcripts while
minimal levels were present in the proliferative and lower
hypertrophic zones (Fig. 10, AV). In contrast, mRNA en-
coding type I collagen was undetectable in the prolifera-
tive and upper hypertrophic zones but was extremely
prominent in the lower hypertrophic zone (Fig. 10, a1(I)).
To ascertain that the different growth plate zones had been
microdissected accurately, blots were hybridized with a
type X collagen cDNA probe. The upper hypertrophic car-
tilage exhibited large amounts of type X collagen tran-
scripts, while no detectable type X collagen transcripts
were found in the proliferative zone, and minimal levels
were present in the lower hypertrophic zone (Fig. 10,
a1(X)).
To ascertain if type I collagen mRNA is expressed by
chondrocytes, we used immunostaining to localize type X
collagen, type I collagen, and annexin V in embryonic tibia
growth plate cartilage. Double immunostaining using anti-
bodies against types X and I collagen revealed that type I
collagen was restricted to a narrow zone of chondrocytes
that bordered the chondro–osseous junction, which also
showed strong immunostaining for type X collagen. In con-
trast, hypertrophic chondrocytes away from the border were
only type X collagen positive, while adjacent osteoid tissue
was immunopositive for type I collagen but not type X col-
lagen (Fig. 11, A and B). Immunostaining with antibodies
against annexin V showed strong staining of the matrix
only in a few cell layers close to the chondro–osseous junc-
tion, while in other areas of the hypertrophic zone staining
for annexin V was restricted to the cell surface (Fig. 11 C).
Immunostaining for annexin V was also observed in the
osteoid matrix (Fig. 11 C). Staining of sections derived
from similar areas with alizarin red S revealed a strong
staining of the narrow type I collagen, type X collagen,
and annexin V–positive zone, demonstrating the codistri-
Figure 5. Electron micro-
graphs of matrix vesicles iso-
lated from vitamin C/phos-
phate-treated chondrocyte
(A–C) and control cultures
(D) and incubated in synthetic
cartilage lymph for 24 and
48 h. Matrix vesicles were
isolated from control and vi-
tamin C/phosphate-treated
chondrocyte cultures as de-
scribed in Materials and
Methods and then incubated
in synthetic cartilage lymph
for 24 and 48 h at 378C. (A)
Freshly isolated matrix vesi-
cles from vitamin C/phos-
phate-treated chondrocyte
cultures without incubation
in synthetic cartilage lymph.
(B and C) Matrix vesicles
isolated from vitamin C/
phosphate-treated cultures
and incubated for 24 (B) and
48 h (C) in synthetic cartilage
lymph. (D) Matrix vesicles
isolated from control cul-
tures and incubated for 48 h
in synthetic cartilage lymph.
Note numerous needle-like crystals associated with matrix vesicles isolated from vitamin C/phosphate-treated cultures, while vesicles
from control cultures showed no evidence of calcification. Bar, 100 nm.Kirsch et al. Mineralization-competent Matrix Vesicles 1155
bution of type I collagen and annexin V in the matrix of
calcified cartilage (Fig. 11 D).
In summary, annexin V is expressed more widely than,
and before, type I collagen in hypertrophic cartilage. How-
ever, both proteins are abundant in the restricted area of
hypertrophic cartilage engaged in calcification.
Discussion
The results of this study demonstrate that matrix vesicle
production can be qualitatively modulated in hypertrophic
chondrocytes. Once the cells become engaged in mineral-
ization under the stimulating activity of vitamin C, they
release vesicles that are annexin V and alkaline phos-
phatase rich and that are able to undergo rapid and effi-
cient mineralization. The mineral associated with these
vesicles is apatitic and is thus quite similar, if not identical,
to mineral that is normally deposited in vivo at the chon-
dro–osseous border during endochondral ossification. Our
results offer an answer to the puzzle posed above, namely
that not all matrix vesicles are created equal, but cells,
such as hypertrophic chondrocytes, have the ability to reg-
ulate the structural composition and functional properties
of the vesicles. It is reasonable to postulate that matrix
vesicles present in tissues not engaged in mineralization,
such as articular cartilage (8, 15, 16, 67), have inadequate
structural composition and are unable to initiate mineral-
ization. What role mineralization-incompetent vesicles may
have, if any, remains to be established.
The vesicles produced by the mineralizing chondrocytes
have all the characteristics needed for the induction of cal-
cification. First, by being extremely rich in alkaline phos-
phatase activity, the vesicles have the capacity to hydro-
lyze a variety of organic phosphate substrates, to increase
substantially the local availability of free phosphate ions,
and to permit their use for apatite crystallization. Such en-
zymatic activity may also remove putative inhibitors of
mineralization, including pyrophosphate (2, 7, 56). Sec-
ond, the vesicles contain a large amount of annexin V. As
summarized above, this membrane-associated protein me-
diates the influx of Ca21 into matrix vesicles, enabling in-
tralumenal crystal growth from the preexisting nucle-
ational core complex (30, 35, 59, 69). Recent molecular
modeling studies have indicated that the protein forms an
hexameric structure that contains a hydrophilic pore selec-
tive for the passage of cations (39). We have confirmed
that annexin V is assembled as a multimeric structure in
the vesicles from mineralizing chondrocytes (31). In addi-
tion, our previous work has shown that annexin V binds
directly to types II and X collagen (32, 34). These interac-
tions may be important for anchoring the vesicles to the fi-
brous components of the matrix and appear to stimulate
Ca21 influx into the vesicles (30, 34). Clearly, by lacking
annexin V, the vesicles produced by nonmineralizing
chondrocytes are not only unable to take up Ca21, which
favors intralumenal crystal growth (Table I and Figs. 3 and
6); they may also “fall off” the matrix and fail to produce
functional extracellular matrix–vesicle interactions. Third,
freshly isolated vesicles contain a relatively high Ca21 and
Pi content, suggesting that they already contain the pre-
formed nucleational core complex rich in Ca21 and Pi. By
having a very low initial Ca21/Pi content, the vesicles from
nonmineralizing cells may not contain a nucleational core
complex and thus are probably unable to carry out crystal
assembly or do so at unphysiologically slow rates. Fourth,
when incubated in synthetic cartilage lymph, the vesicles
form needle-like crystals (Fig. 5), while vesicles from non-
mineralizing cells are unable to form crystals. FT-IR anal-
ysis of the n1n3 and n4 phosphate domains indicates that
the vesicles from mineralizing cells generate well crystal-
lized apatite (Fig. 6).
The assembly of mineralization-competent vesicles thus
requires a coordinated effort on the part of the chondro-
cytes such that multiple specific components all appear in
these vesicles. Matrix vesicle assembly must require se-
questering mechanisms reminiscent of those involved in
assembly of exo- and endocytotic vesicles. For instance,
Figure 6. FT-IR spectra of matrix vesicles isolated from vitamin
C/phosphate-treated or control chondrocyte cultures. (A, C, and
E) Second derivative spectra of the n1n3 phosphate region of ma-
trix vesicles isolated from vitamin C/phosphate-treated chondro-
cyte cultures and incubated in synthetic cartilage lymph for 24 h
at 378C (A), matrix vesicles isolated from control cultures and in-
cubated in synthetic cartilage lymph for 24 h at 378C (C), and hy-
droxyapatite (E). Note that in A, peaks can be seen at 960, 1,025,
1,065, 1,102 and 1,157 cm21, while these bands are absent in ma-
trix vesicles from control cultures (C). Also note the similarity of
the spectra of mineralizing matrix vesicles (A) and hydroxyapa-
tite (E). (B, D, and F) Second derivative structure in the n4 do-
mains (640–500 cm21) of matrix vesicles isolated from vitamin C/
phosphate-treated cultures (B), matrix vesicles isolated from con-
trol cultures (D), and hydroxyapatite (F). Note that peaks at 626
and 539 cm21, characteristic of HPO4 apatites, were clearly evi-
dent in mineralizing vesicle samples (B) but were markedly re-
duced in control samples (D). Both samples contained peaks at
561, 576, and 602 cm21, which are representative of phosphate
ions. Also note the similarity of the spectra of mineralizing matrix
vesicles (B) and hydroxyapatite (F).The Journal of Cell Biology, Volume 137, 1997 1156
our data show that vitamin C stimulates alkaline phos-
phatase activity about 2-fold in total cell homogenates; in
striking contrast, such activity is stimulated over 300-fold
in matrix vesicles. Thus, the chondrocytes must possess
mechanisms to concentrate the enzyme, which is phos-
phatidylinositol linked (24, 61, 66), in the nascent matrix
vesicles before budding off the cell surface. Similar con-
centration mechanisms must also be involved in selecting
the lipid composition of the matrix vesicles, which is mark-
edly different from the lipid composition of the chondro-
cyte membrane and, in particular, is phosphatidylserine
rich (51, 70). We should point out that hypertrophic chon-
drocytes exhibit elevated levels of intracellular calcium
(22, 27, 35); interestingly, calcium is required for binding
and association of annexin V with the membrane (19).
Thus, elevated levels of intracellular calcium could facili-
tate the association of annexin V with the membrane in-
side the chondrocytes; assembly processes such as those
above may then concentrate annexin V in nascent matrix
vesicles. In addition, the high intracellular calcium concen-
tration might also be required for the formation of the nu-
cleational core complex inside the cells before the release
of the vesicles into extracellular matrix (69). In this regard,
it will be interesting to determine whether vitamin C treat-
ment increases the intracellular calcium concentration in
chondrocytes, thus favoring annexin V/matrix vesicle as-
sembly. Because matrix vesicles are produced by nonmin-
eralizing chondrocytes but are alkaline phosphatase, an-
nexin V, and Ca21/Pi poor, it seems, however, that these
three components may not have a major direct role in ves-
icle assembly and budding per se.
Matrix vesicles produced by mineralizing chondrocytes
also contain types II and X collagen, which are not present
in vesicles produced by nonmineralizing chondrocytes, con-
firming previous studies showing that binding of types II
and X collagen to matrix vesicles is mediated by annexin V
(32, 35, 68). In addition, our previous studies have pro-
vided evidence that surface-attached collagens (types II
and X) play an important role in stimulating influx of Ca21
into matrix vesicles that already contain a preformed nu-
Figure 7. Proteoglycan content in control and mineralizing matrix vesicle preparations. Aliquots of matrix vesicle preparations isolated
from control cultures (B, Control) or vitamin C/phosphate-treated chondrocyte cultures (B, Vit.C/Pi) were dotted onto nitrocellulose fil-
ters and immunostained with antibodies against aggrecan as described in Materials and Methods. (A) Different concentrations of puri-
fied aggrecan were dotted onto nitrocellulose filters and immunostained with antibodies against aggrecan. Densitometry was used to
calculate the amount of aggrecan in the vesicle preparations using the staining intensities of the aggrecan dots as a standard curve. (C
and D) EDS analysis of control matrix vesicles (C) and mineralizing matrix vesicles (D). Note that both vesicle preparations contain sim-
ilar amounts of sulfur (peaks labeled with S; 77 counts in control matrix vesicles; 64 counts in mineralizing matrix vesicles). Also note
that Ca21 peaks are only present in mineralizing matrix vesicles (D, peaks labeled with Ca); in addition, mineralizing matrix vesicles
contain more phosphate (peaks labeled with P) than control matrix vesicles.
Figure 8. Expression of an-
nexin V (AV), type X col-
lagen (a1(X)), and type I col-
lagen (a1(I)) genes in control
and vitamin C/phosphate-
treated chondrocyte cultures.
Cultures of day 19 chick em-
bryonic hypertrophic tibia
chondrocytes were main-
tained in culture in DMEM
containing 10% FCS. When
the cells had reached conflu-
ency, half of the cultures re-
ceived 50 mg/ml of freshly
prepared vitamin C and 2.5
mM phosphate; the medium of both the treated ( 1 Vit.C/Pi)
and control (2 Vit.C/Pi) cultures was changed daily. After 7 or
14 d, total RNA was isolated from the control cultures or supple-
mented cultures and subjected to Northern blot analysis using
annexin V, type X, and type I collagen 32P-labeled cDNA
probes.Kirsch et al. Mineralization-competent Matrix Vesicles 1157
cleational core complex inside their lumen (30, 34); how-
ever, these collagens are not able to initiate mineralization
by themselves in the absence of matrix vesicles (30, 34).
Thus, by having annexin V, surface-attached collagens, and
a preformed nucleational core complex, matrix vesicles
produced by mineralizing chondrocytes can actively take
up Ca21 and induce mineralization. Matrix vesicles pro-
duced by nonmineralizing chondrocytes lack annexin V,
surface-attached collagens, and a nucleational core and
thus are unable to accumulate mineral ions.
As summarized above, it has been proposed that focal
accumulations of proteoglycans in the hypertrophic zone
may serve as the nucleational site for calcification (25, 26,
53). However, our results show that matrix vesicles iso-
lated from both control and mineralizing cultures contain
similar amounts of proteoglycans, indicating that pro-
teoglycans do not play a major role in the initial phase of
mineralization mediated by matrix vesicles, when the first
crystal phase grows inside the vesicle lumen (6). These
findings are in agreement with a previous study showing
that removal of proteoglycans from matrix vesicle prepa-
rations from hypertrophic cartilage does not change their
ability to take up Ca21 (69). Our data do not exclude the
possibility that once the crystals rupture the vesicle mem-
brane and penetrate the extracellular matrix, proteogly-
cans might still be involved in regulating apatite deposi-
tion and growth.
It is not surprising that hypertrophic chondrocytes de-
pend on the stimulating activity of vitamin C to assemble
mineralization-competent vesicles. It is quite likely that
mineralization in vivo depends on a variety of exogenous
cues and factors as well. We have shown previously that
retinoic acid is also a powerful and efficient inducer of
Figure 9. Immunofluores-
cence staining of chondro-
cyte cultures with antibodies
against annexin V (Annexin
V), type X (Type X), and
type I collagen (Type I).
Chondrocytes isolated from
day 19 chick embryonic tibia
cartilage were maintained in
culture until confluent. They
were then grown for addi-
tional 7 or 14 d in the ab-
sence (Control) or presence
of vitamin C (50 mg/ml) and
phosphate (2.5 mM; Vit.C/Pi)
and then immunostained for
annexin V, type X, and type I
collagen. Note that after 14 d,
control cultures were posi-
tive for annexin V (A) and
type X collagen (B) but
showed no staining for type I
collagen (C). After 7 d of
treatment with vitamin C and
phosphate, chondrocytes
were positive for annexin V
(D) and type X collagen (E)
and exhibited no staining for
type I collagen (F). After 14 d
of treatment, chondrocytes
showed strong staining for
annexin V (G), type X col-
lagen (H), and type I collagen
(I). Bar, 100 mm.
Figure 10. Northern blot
analysis showing annexin V
(AV), type X collagen
(a1(X)), and type I collagen
(a1(I)) in different zones of
growth plate cartilage. RNA
(10  mg/lane) isolated from
the proliferative zone (PZ),
upper hypertrophic zone
(UHZ), and lower hyper-
trophic, calcifying zone
(LHZ) of day 19 chick em-
bryonic tibia were separated
on agarose gels, blotted onto
nylon membranes, and hy-
bridized to 32P-labeled an-
nexin V (AV), type X col-
lagen (a1(X)), and type I
collagen (a1(I)) cDNA
probes. Note the presence of
high amounts of annexin V
and type X collagen message
in the upper hypertrophic
zone; in contrast, a1(I) is
confined to the lower hyper-
trophic, calcifying zone.The Journal of Cell Biology, Volume 137, 1997 1158
mineralization in chondrocytes (28, 29). Indeed, both lack
of vitamin A or excessive amounts of it cause severe skele-
tal defects and produce abnormal cartilage mineralization
(43, 60). Vitamin C and retinoic acid do not function as
“master switches” such that the entire mineralization pro-
gram is turned on at once. Rather, they appear to act as
triggers that initiate a subsequent sequence of temporally
separable events. This is exemplified by our findings that
vitamin C treatment first leads to stimulation of alkaline
phosphatase activity and annexin V gene expression and
then to induction of type I collagen expression and matrix
mineralization. Thus, cues such as vitamin C seem to trig-
Figure 11. Localization of type X collagen, type I collagen, annexin V, and calcium deposits in growth plate cartilage. Longitudinal sec-
tions of day 19 chick embryonic tibia growth plate cartilage were double stained with antibodies against type X (A) and I collagen (B) or
antibodies against annexin V (C). Sections derived from similar areas were stained with alizarin red S (D). Double staining demonstrated a
colocalization of type X (A) and type I collagen (B) in the lower hypertrophic cartilage zone. Type I collagen staining was detected in 3–5
cell layers close to the chondro–osseous junction (arrows). Alizarin red S staining confirmed that these type I collagen-positive cartilage
regions were calcified (D, arrow). Immunostaining with antibodies against annexin V revealed strong staining of the matrix only in the
lower hypertrophic (calcified) cartilage zone, while staining for annexin V in hypertrophic cartilage was restricted to the cell surface (C).
HZ, hypertrophic zone; MZ, mineralized zone; O, osteoid. Bar, 100 mm.Kirsch et al. Mineralization-competent Matrix Vesicles 1159
ger or stimulate the expression of the chondrocyte-endog-
enous developmental program, which then proceeds ac-
cording to an endogenously controlled sequence. We
demonstrate here that a similar sequence of phenotypic
events characterizes the hypertrophic zone of growth plate
in vivo in which we observe the presence of annexin V first
and the codistribution of annexin V and type I collagen
later at the mineralizing border. How this sequence of
events is controlled in vivo and in vitro and what cellular
and molecular mechanisms are involved remains to be
worked out. For instance, both vitamin C and phosphate
have been found to change the thiol status of chondrocytes
undergoing terminal maturation (62); since thiol levels can
regulate the expression of a number of matrix genes, it is
plausible that thiol levels could affect the expression of an-
nexin V, type I collagen, as well as type X collagen in ma-
turing and mineralizing chondrocytes.
Previous studies have shown that in turkey tendons the
apatitic crystals emanating from matrix vesicles grow along
type I collagen fibrils (9, 10, 13, 36). Based on the highly
oriented nature and parallel alignment of type I collagen
fibrils, these fibrils probably provide an ideal environment
for further crystal growth. Our data now demonstrate that
hypertrophic chondrocytes engaged in mineralization in
culture produce and deposit extracellularly large amounts
of type I collagen; we also show that the mineralizing chon-
drocytes at the chondro–osseous border in vivo display
type I collagen in their matrix. Since matrix vesicles iso-
lated from mineralizing chondrocyte cultures do not con-
tain type I collagen and are able to initiate calcification
when incubated in synthetic cartilage lymph (Table I and
Figs. 5 and 6), it is likely that this collagen is not involved
in the initiation and nucleation of the first crystal phase.
However, as in the case of tendons, this collagen may offer
a structure onto which crystals can grow and propagate in
appropriate spatial directions.
Type I collagen may also play an additional, important
function. It may provide for a smooth transition from the
type II/X collagen-rich cartilage matrix to the type I col-
lagen-rich bone matrix. It may also reinforce the mechani-
cal properties of the chondro–osseous border, helping this
heterogeneous and highly dynamic structure maintain
structural integrity.
The onset of synthesis of type I collagen in chondrocytes
should be discussed in relation to previous studies on a re-
lated issue. Chondrocytes have long been known to have
the capacity to initiate type I collagen synthesis once
placed in culture (12, 44, 54, 64). This finding has been tra-
ditionally interpreted to signify that chondrocytes are phe-
notypically unstable and can rapidly dedifferentiate into
fibroblast-like cells (12, 44, 54, 64). In more recent studies,
type I collagen synthesis by chondrocytes has been given
an alternative interpretation, namely that it indicates that
the chondrocytes “transdifferentiate” into osteoblast-like
cells (18, 57, 58). However, our findings demonstrate that
hypertrophic chondrocytes do not necessarily have to un-
dergo “transdifferentiation” to osteoblastic cells to express
type I collagen. Instead, morphologically identifiable, type
X collagen-positive chondrocytes express type I collagen
in concert with matrix calcification. Thus, mineralizing hy-
pertrophic chondrocytes acquire and express most of the
phenotypic characteristics of osteoblasts, including high al-
kaline phosphatase activity and expression of osteonectin
and type I collagen (28, 29, 35, 37, 45, 48), while maintain-
ing unique properties such as hypertrophy or type X col-
lagen synthesis. In line with our conclusions above, it may
be that these phenotypic traits shared with osteoblasts are
needed not only to bring about the final phase of endo-
chondral ossification, that is, the replacement of mineral-
ized cartilage with bone; they may also permit mineralized
cartilage to act as bone-like structure and tissue and allow
for a seamless structural–functional transition from carti-
lage to bone.
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